Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

Clinical trial NCT00159614 · COMPLETED

Trial details

NCT number

NCT00159614

Sponsor

NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2005-09-01

Enrollment

30

View on ClinicalTrials.gov